( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Mohammad Haroon Gouri*, Rajkumar Rathore, Pratiksha Ladla, Monika Sharma and Archana Vyas


Background: Respiratory tract infections have high and frequent incidence and thus are among the most important human health problems. The antimicrobials are commonly used in ENT departments. Thus prescription-auditing involving the utilization patterns of antimicrobials should be done time to time to ensure their rational use. Methods: A prospective, cross –sectional, observational study was done for 6 months (Sept. 2019 to Feb. 2020) In the ENT OPD of MDM hospital, a tertiary care hospital associated with Dr. S. N. Medical College, Jodhpur for treatment of common ENT diseases. The data was analyzed in form of frequency and percentage. Results: Total 782 prescriptions were analyzed. Out of which, 417 were of male patients (53.32%) and 365 (46.67%) of female patients. All 3278 drugs prescribed were in their generic names and from list of essential medicines (100%) for state of Rajasthan. Average number of drugs per encounter were found to be 4.19. Antimicrobials (24.87%) were most commonly prescribed (including oral, topical and parentral route), followed by NSAIDs (23.39%), antihistaminics (15.33%), vitamin supplements (12.80%), anti-ulcer drugs (9.58%), nasal decongestants (4.92%), corticosteroids (3.84%), antiseptics (1.00%) and others (4.22%). Most frequently used antimicrobials were cefixime (27.99%), followed by ciprofloxacin (24.59%), amoxicillin + clavulanic acid (24.22%), clotrimazole (11.96%) and neomycin (4.71%). Total number of antimicrobials prescribed in this study were 1061, out of which total number of antibiotics were 934 (88.03%) and antifungals prescribed were 127 (11.97%). Conclusion: Cefixime (27.99%), followed by ciprofloxacin (24.59%) were most frequently used antimicrobials in our study. The use of the generic name was found to be satisfactory, but the average number of drug per prescription was high. An antibiotic policy has to be developed for the doctors in treating infections so that rationality in using the antibiotics will be developed and the occurrence of antibiotic resistance can be reduced.

Keywords: Antimicrobials, ENT, drug utilisation pattern.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.


    FEBRUARY 2024 issue has been successfully launched on 1 FEBRUARY 2024.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 February 2024 Issue has been Published, Kindly check it on

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia